Perburukan Asma Bronkial Sebelum clan Saat Pandemi COVID-19 pads Periode Januari 2019-April 2023

Celline Margareth Winarto, Agus Cahyono, Olivia Benedick Sri Panggabean, Agus Suharto
Bukit Palma A2 24 Citraland Utara, Surabaya

Abstract

Background: Asthma is a chronic respiratory disease that poses a serious public health problem in various countries around the world. Asthma can be mild and not interfere with activities, but it can also be persistent and disrupt daily activities. Individuals with persistent asthma experience a decline in physical condition, limiting their ability to carry out daily activities. According to WHO (World Health Organization) data, the global prevalence of asthma reached 262 million in 2019. The prevalence of asthma in Indonesia, according to data from the Indonesian Ministry of Health, reached 12 million in 2020. During the COVID-19 pandemic, asthma patients did not attend routine hospital check-ups due to fear of exposure to COVID-19, resulting in worsening symptoms and depletion of their medications.
Research Methods : This study is a quantitative observational analytic research with a retrospective approach. The research was conducted by collecting medical record data from 30 outpatients with bronchial asthma in the pulmonary outpatient clinic of Haji Surabaya Provincial Hospital and Ibnu Sina Gresik Hospital in August-October 2023. Data were tested using the Mc Nemar comparison test, revealing 16 samples that showed deterioration according to the Mc Nemar test results.
Results: The research findings from the non-parametric Mc Nemar comparison test indicate a significance value of 0.808, and 23 samples deteriorated based on the Mc Nemar test results, suggesting no significant difference in the exacerbation of bronchial asthma before and during the COVID-19 pandemic.
Conclusion: There is no difference in exacerbation of bronchial asthma before and during the COVID-19 pandemic.
Keyword: Bronchial asthma, Exacerbation of bronchial asthma, COVID-19 pandemic.